← Back to Search

Computer Image Analysis for Skin Conditions

N/A
Recruiting
Led By Raja Sivamani, MD, MS, AP
Research Sponsored by Integrative Skin Science and Research
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Adults unable to consent
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights
No Placebo-Only Group

Summary

This trial tests if computer images can accurately judge skin conditions.

Who is the study for?
This trial is for adults with acne, rosacea, melasma, or seborrheic dermatitis. Participants must be able to give consent and should not have facial markings like piercings or tattoos that could affect the imaging process on the day of facial photography.
What is being tested?
The study aims to see if computer-based image grading can accurately assess the severity of skin conditions such as acne, melasma, rosacea, and seborrheic dermatitis compared to expert clinical evaluations.
What are the potential side effects?
Since there are no interventions like medications or procedures being tested in this trial—only image analysis—participants are not expected to experience any direct side effects from participating.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am unable to give consent for medical procedures.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Correlation of image-based grading to clinical gradings for acne
Correlation of image-based grading to clinical gradings for melasma
Correlation of image-based grading to clinical gradings for rosacea
+1 more
Secondary study objectives
Sebum excretion rate

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

4Treatment groups
Experimental Treatment
Group I: Seborrheic DermatitisExperimental Treatment1 Intervention
Grading of seborrheic dermatitis with Seborrheic Dermatitis Area Severity Index score
Group II: RosaceaExperimental Treatment1 Intervention
Inflammatory lesion count
Group III: MelasmaExperimental Treatment1 Intervention
Pigment intensity and distribution with use of Melasma Area Severity Index
Group IV: Acne vulgarisExperimental Treatment1 Intervention
Inflammatory and non-inflammatory lesion counts

Find a Location

Who is running the clinical trial?

Integrative Skin Science and ResearchLead Sponsor
32 Previous Clinical Trials
1,824 Total Patients Enrolled
1 Trials studying Rosacea
24 Patients Enrolled for Rosacea
Codex LabsUNKNOWN
1 Previous Clinical Trials
36 Total Patients Enrolled
Raja Sivamani, MD, MS, APPrincipal InvestigatorIntegrative Skin and Research

Media Library

Acne vulgaris Clinical Trial Eligibility Overview. Trial Name: NCT05942248 — N/A
Rosacea Research Study Groups: Acne vulgaris, Rosacea, Melasma, Seborrheic Dermatitis
Rosacea Clinical Trial 2023: Acne vulgaris Highlights & Side Effects. Trial Name: NCT05942248 — N/A
Acne vulgaris 2023 Treatment Timeline for Medical Study. Trial Name: NCT05942248 — N/A
~16 spots leftby Jan 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top